Prescription Opioid Exposures Among Children and Adolescents in the United States: 2000–2015 JD Allen, MJ Casavant, HA Spiller, T Chounthirath, NL Hodges, GA Smith Pediatrics 139 (4), e20163382, 2017 | 168 | 2017 |
Consequences of use of anabolic androgenic steroids MJ Casavant, K Blake, J Griffith, A Yates, LRM Copley Pediatric Clinics of North America 54 (4), 677-690, 2007 | 143 | 2007 |
Could chest wall rigidity be a factor in rapid death from illicit fentanyl abuse? G Burns, RT DeRienz, DD Baker, M Casavant, HA Spiller Clinical Toxicology 54 (5), 420-423, 2016 | 110 | 2016 |
Pediatric exposure to laundry detergent pods AL Valdez, MJ Casavant, HA Spiller, T Chounthirath, H Xiang, GA Smith Pediatrics 134 (6), 1127-1135, 2014 | 100 | 2014 |
Pediatric exposure to e-cigarettes, nicotine, and tobacco products in the United States A Kamboj, HA Spiller, MJ Casavant, T Chounthirath, GA Smith Pediatrics 137 (6), 2016 | 99 | 2016 |
Sex-and age-specific increases in suicide attempts by self-poisoning in the United States among youth and young adults from 2000 to 2018 HA Spiller, JP Ackerman, NE Spiller, MJ Casavant The Journal of pediatrics 210, 201-208, 2019 | 94 | 2019 |
Out-of-hospital medication errors among young children in the United States, 2002–2012 MD Smith, HA Spiller, MJ Casavant, T Chounthirath, TJ Brophy, H Xiang Pediatrics 134 (5), 867-876, 2014 | 92 | 2014 |
Marijuana exposure among children younger than six years in the United States B Onders, MJ Casavant, HA Spiller, T Chounthirath, GA Smith Clinical pediatrics 55 (5), 428-436, 2016 | 90 | 2016 |
Suicide attempts by self-poisoning in the United States among 10–25 year olds from 2000 to 2018: substances used, temporal changes and demographics HA Spiller, JP Ackerman, GA Smith, S Kistamgari, AR Funk, ... Clinical toxicology 58 (7), 676-687, 2020 | 70 | 2020 |
E-cigarette and liquid nicotine exposures among young children P Govindarajan, HA Spiller, MJ Casavant, T Chounthirath, GA Smith Pediatrics 141 (5), e20173361, 2018 | 67 | 2018 |
An increase in dietary supplement exposures reported to US Poison Control Centers N Rao, HA Spiller, NL Hodges, T Chounthirath, MJ Casavant, AK Kamboj, ... Journal of medical toxicology 13, 227-237, 2017 | 54 | 2017 |
A 9-state analysis of designer stimulant,“bath salt,” hospital visits reported to poison control centers BJ Warrick, M Hill, K Hekman, R Christensen, R Goetz, MJ Casavant, ... Annals of emergency medicine 62 (3), 244-251, 2013 | 54 | 2013 |
Urine drug screening in adolescents MJ Casavant Pediatric Clinics 49 (2), 317-327, 2002 | 52 | 2002 |
Pediatric exposures to laundry and dishwasher detergents in the United States: 2013–2014 MG Davis, MJ Casavant, HA Spiller, T Chounthirath, GA Smith Pediatrics 137 (5), 2016 | 48 | 2016 |
Does fluorescent urine indicate antifreeze ingestion by children? MJ Casavant, MN Shah, R Battels Pediatrics 107 (1), 113-114, 2001 | 46 | 2001 |
Buprenorphine exposures among children and adolescents reported to US poison control centers S Post, HA Spiller, MJ Casavant, T Chounthirath, GA Smith Pediatrics 142 (1), e20173652, 2018 | 40 | 2018 |
Non-health care facility medication errors resulting in serious medical outcomes NL Hodges, HA Spiller, MJ Casavant, T Chounthirath, GA Smith Clinical Toxicology 56 (1), 43-50, 2018 | 38 | 2018 |
Atomoxetine-induced hepatitis in a child SD Stojanovski, MJ Casavant, HM Mousa, P Baker, MC Nahata Clinical Toxicology 45 (1), 51-55, 2007 | 38 | 2007 |
An observational study of the factor Xa inhibitors rivaroxaban and apixaban as reported to eight poison centers HA Spiller, JB Mowry, A Aleguas Jr, JRK Griffith, R Goetz, ML Ryan, ... Annals of emergency medicine 67 (2), 189-195, 2016 | 37 | 2016 |
Medication errors reported to US Poison Control Centers, 2000–2012 TJ Brophy, HA Spiller, MJ Casavant, T Chounthirath, MD Smith, H Xiang Clinical toxicology 52 (8), 880-888, 2014 | 37 | 2014 |